|
1
|
Correa P: Human gastric carcinogenesis: a
multistep and multifactorial process - First American Cancer
Society Award Lecture on Cancer Epidemiology and Prevention. Cancer
Res. 52:6735–6740. 1992.
|
|
2
|
Sands BE and Podolsky DK: The trefoil
peptide family. Annu Rev Physiol. 58:253–273. 1996. View Article : Google Scholar
|
|
3
|
Thim L: Trefoil peptides: from structure
to function. Cell Mol Life Sci. 53:888–903. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fox JG, Rogers AB, Whary MT, et al:
Accelerated progression of gastritis to dysplasia in the pyloric
antrum of TFF2 −/− C57BL6 x Sv129 Helicobacter
pylori-infected mice. Am J Pathol. 171:1520–1528.
2007.PubMed/NCBI
|
|
5
|
Fujimoto J, Yasui W, Tahara H and Tahara
E, Kudo Y, Yokozaki H and Tahara E: DNA hypermethylation at the pS2
promoter region is associated with early stage of stomach
carcinogenesis. Cancer Lett. 149:125–134. 2000. View Article : Google Scholar
|
|
6
|
Machado JC, Carneiro F, Ribeiro P, Blin N
and Sobrinho-Simões M: pS2 protein expression in gastric carcinoma.
An immunohistochemical and immunoradiometric study. Eur J Cancer.
32A:1585–1590. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taupin D, Pedersen J, Familari M, Cook G,
Yeomans N and Giraud AS: Augmented intestinal trefoil factor (TFF3)
and loss of pS2 (TFF1) expression precedes metaplastic
differentiation of gastric epithelium. Lab Invest. 81:397–408.
2001. View Article : Google Scholar
|
|
8
|
Taupin DR, Kinoshita K and Podolsky DK:
Intestinal trefoil factor confers colonic epithelial resistance to
apoptosis. Proc Natl Acad Sci USA. 97:799–804. 2000. View Article : Google Scholar
|
|
9
|
Yamachika T, Werther JL, Bodian C, et al:
Intestinal trefoil factor: a marker of poor prognosis in gastric
carcinoma. Clin Cancer Res. 8:1092–1099. 2002.PubMed/NCBI
|
|
10
|
Wong WM, Poulsom R and Wright NA: Trefoil
peptides. Gut. 44:890–895. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Farrell JJ, Taupin D, Koh TJ, et al:
TFF2/SP-deficient mice show decreased gastric proliferation,
increased acid secretion, and increased susceptibility to NSAID
injury. J Clin Invest. 109:193–204. 2002. View Article : Google Scholar
|
|
12
|
Dhar DK, Wang TC, Maruyama R, et al:
Expression of cytoplasmic TFF2 is a marker of tumor metastasis and
negative prognostic factor in gastric cancer. Lab Invest.
83:1343–1352. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim H, Eun JW, Lee H, Nam SW, Rhee H, Koh
KH and Kim KH: Gene expression changes in patient-matched gastric
normal mucosa, adenomas, and carcinomas. Exp Mol Pathol.
90:201–209. 2011. View Article : Google Scholar
|
|
14
|
Hu GY, Yu BP, Dong WG, et al: Expression
of TFF2 and Helicobacter pylori infection in carcinogenesis
of gastric mucosa. World J Gastroenterol. 9:910–914.
2003.PubMed/NCBI
|
|
15
|
Shi SQ, Cai JT and Yang JM: Expression of
trefoil factors 1 and 2 in precancerous condition and gastric
cancer. World J Gastroenterol. 12:3119–3122. 2006.PubMed/NCBI
|
|
16
|
Paoletti X, Oba K, Burzykowski T, et al:
Benefit of adjuvant chemotherapy for resectable gastric cancer: a
meta-analysis. JAMA. 303:1729–1737. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Yu G, Wang Y, et al: Activation
of protease-activated receptor (PAR) 1 by frog trefoil factor (TFF)
2 and PAR4 by human TFF2. Cell Mol Life Sci. 68:3771–3780. 2011.
View Article : Google Scholar
|
|
18
|
Kononen J, Bubendorf L, Kallioniemi A, et
al: Tissue microarrays for high-throughput molecular profiling of
tumor specimens. Nat Med. 4:844–847. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu SB, He YY, Zhang Y, et al: A novel
non-lens betagamma-crystallin and trefoil factor complex from
amphibian skin and its functional implications. PLoS One.
3:e17702008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
|
|
21
|
Gratio V, Walker F, Lehy T, Laburthe M and
Darmoul D: Aberrant expression of proteinase-activated receptor 4
promotes colon cancer cell proliferation through a persistent
signaling that involves Src and ErbB-2 kinase. Int J Cancer.
124:1517–1525. 2009. View Article : Google Scholar
|
|
22
|
Moss SF, Lee JW, Sabo E, et al: Decreased
expression of gastrokine 1 and the trefoil factor interacting
protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology
and relationship to prognosis. Clin Cancer Res. 14:4161–4167. 2008.
View Article : Google Scholar
|
|
23
|
Halldórsdóttir AM, Sigurdardóttrir M,
Jónasson JG, et al: Spasmolytic polypeptide-expressing metaplasia
(SPEM) associated with gastric cancer in Iceland. Dig Dis Sci.
48:431–441. 2003.
|
|
24
|
Yamaguchi H, Goldenring JR, Kaminishi M
and Lee JR: Identification of spasmolytic polypeptide expressing
metaplasia (SPEM) in remnant gastric cancer and surveillance
postgastrectomy biopsies. Dig Dis Sci. 47:573–578. 2002. View Article : Google Scholar
|
|
25
|
Jones PA and Laird PW: Cancer epigenetics
comes of age. Nat Genet. 21:163–167. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peterson AJ, Menheniott TR, O’Connor L, et
al: Helicobacter pylori infection promotes methylation and
silencing of trefoil factor 2, leading to gastric tumor development
in mice and humans. Gastroenterology. 139:2005–2017. 2010.
View Article : Google Scholar
|
